COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,843 Articles (22,553 medRxiv, 8,290 bioRxiv)

Most recent first Previous |  Page 502: Articles 5011-5020  | Next

Molecular identification of SARS-CoV-2 variants of concern at urban wastewater treatment plants across South Africa
Yousif, M., Rachida, S., Taukobong, S., Ndlovu, N., Iwu-Jaja, C., Howard, W., Moonsamy, S., Mhlambi, N., Gwala, S., Levy, J., Andersen, K., Scheepers, C., von Gottberg, A., Wolter, N. I., Ismail, A., Suchard, M., McCarthy, K.
10.1101/2022.12.15.22283506 — Posted: 2022-12-16
Estimating measures to reduce the transmission of SARS-CoV-2 in Australia to guide a 'National Plan' to reopening
Ryan, G. E., Shearer, F. M., McCaw, J., McVernon, J., Golding, N.
10.1101/2022.12.15.22282869 — Posted: 2022-12-16
SARS-CoV-2-associated mortality with a principal cause other than COVID-19 during the Omicron epidemic in France and detection and treatment of Omicron infections in associated complications
Goldstein, E.
10.1101/2022.12.15.22283529 — Posted: 2022-12-16
Synthesizing evidence on the impacts of COVID-19 regulatory changes on methadone treatment for opioid use disorder: Implications for U.S. federal policy
Krawczyk, N., Rivera, B. D., Levin, E., Dooling, B. C. E.
10.1101/2022.12.15.22283533 — Posted: 2022-12-16
Effect of Ivermectin 600 mcg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial
Naggie, S., Boulware, D. R., Lindsell, C. J., Stewart, T. G., Lim, S. C., Cohen, J., Kavtaradze, D., Amon, A. P., Gabriel, A., Gentile, N., Felker, G. M., Rothman, R. L., Jayaweera, D., McCarthy, M. W., Sulkowski, M., Wilson, S., DeLong, A., Remaly, A., Wilder, R., Collins, S., Dunsmore, S. E., Adam, S. J., Thicklin, F., Hanna, G., Ginde, A. A., Castro, M., McTigue, K., Shenkman, E., Hernandez, A. F.
10.1101/2022.12.15.22283488 — Posted: 2022-12-15
The estimated disease burden of COVID-19 in Japan from 2020 to 2021
Tsuzuki, S., Beutels, P.
10.1101/2022.12.14.22283492 — Posted: 2022-12-15
SARS-CoV-2 causes periodontal fibrosis by deregulating mitochondrial beta-oxidation
Gao, Y., Kok, W. L., Sharma, V., Illsley, C. S., Hanks, S., Tredwin, C., Hu, B.
10.1101/2022.12.15.520561 — Posted: 2022-12-15
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T-cell recognition epitopes
Muik, A., Lui, B. G., Diao, H., Fu, Y., Bacher, M., Toker, A., Grosser, J., Ozhelvaci, O., Grikscheit, K., Hoehl, S., Kohmer, N., Lustig, Y., Regev-Yochay, G., Ciesek, S., Beguir, K., Poran, A., Tuereci, O., Sahin, U.
10.1101/2022.12.15.520569 — Posted: 2022-12-15
Crowdsourcing Temporal Transcriptomic Coronavirus Host Infection Data: resources, guide, and novel insights.
Flynn, J., Ahmadi, M., McFarland, C., Kubal, M., Taylor, M., Cheng, Z., Torchia, E. C., Edwards, M.
10.1101/2022.12.14.520483 — Posted: 2022-12-15
Understanding the mechanism of the SARS CoV-2 coinfection with other respiratory viruses
Ponnusamy, K., Srinivasan, R. V., Marwal, R., Datta, M., Dhar, M. S., Chaudhary, U., Sharma, U., Kumari, S., Sharma, K., Gogia, H., Madan, P., Kabra, S., Rakshit, P.
10.1101/2022.12.15.520197 — Posted: 2022-12-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).